From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Enteq Technologies – notes progress on “unique” SABER product, so why a more than 30% share price slump?

By Steve Moore | Wednesday 21 September 2022


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


An “AGM trading statement” from Enteq Technologies (NTQ) includes “increased number of active North American drilling rigs during the period, rising from approx. 700 at the start of April to approx. 760 currently” and “SABER, the unique Rotary Steerable Drilling product, based on IP from Shell and subsequent Enteq developments has now successfully passed all stages of passive testing… a full active drilling test site has been booked in Norway and commercial agreements for field trials, initially in the Middle East, are being concluded with the expectation of commercial operations closer to the end of this calendar year”. Good news then from this “energy services technology and equipment supplier”?

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 15:21:10